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24 Protocol registration and changes
25 This publication is an update of a protocol first registered in the International Prospective Register of 
26 Systematic Reviews (PROSPERO) on June 9 2017 and updated on XX XX 2018 (registration number 
27 CRD42017068861, http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017068861).
28 All elements of the protocol have been adjusted to adhere with best practices for systematic reviews. Apart 
29 from preliminary searches in scientific databases to assist in the design of search strings, no work on the 
30 systematic review was performed before the protocol was changed.
31
Commented [1]:  The PROSPERO registration will be updated in 
accordance with this manuscript, once the manuscript is approved.
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32 Abstract
33 Title
34 Exposure to neuroactive non-organochlorine insecticides, and diabetes mellitus and related metabolic 
35 disturbances: Protocol for a systematic review and meta-analysis
36 Objectives
37 To assess whether exposure to specific classes of neuroactive non-organochlorine insecticides at levels too 
38 low to cause acute intoxication is associated with diabetes mellitus or related metabolic traits.
39 Methods
40 Eligibility criteria
41 Any type of epidemiological and human exposure studies providing an exposure contrast to neuroactive non-
42 organochlorine insecticides and a measure of association to diabetes mellitus or related metabolic traits. We 
43 will include published peer-reviewed studies in both English and non-English language.
44 Information sources
45 Articles will be located in the NCBI PubMed, Embase, Scopus, Web of Science and LILACS databases, 
46 supplemented with manual searching of reference lists and articles citing the included studies.
47 Risk of bias assessment
48 Risk of bias in individual studies will be assessed using tools from the Navigation Guide systematic review 
49 methodology, while the risk of bias at the outcome level will be assessed according to the Grading of 
50 Recommendations Assessment, Development, and Evaluation (GRADE) guidelines.
51 Data synthesis and analysis
52 When studies are sufficiently similar in population, exposure, comparator and effect estimate to 
53 meaningfully allow quantitative synthesis, we will perform meta-analysis. Otherwise, results will be 
54 summarized qualitatively.
55 Funding
56 The development of this protocol was not supported by any specific grant from funding agencies in the 
57 public, commercial, or not-for-profit sectors. 
58 Registration
59 PROSPERO CRD42017068861.
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60 1 Background
61 Diabetes mellitus is a heterogeneous group of diseases characterized by varying degrees of insulin 
62 insensitivity, decreased insulin production and hyperglycaemia.1 The global prevalence of diabetes mellitus 
63 has been rapidly increasing over the last decades, reaching 8.5% in 2014,2 and it is estimated that 3.7 million 
64 people die annually as a consequence of diabetes mellitus or higher-than-optimal blood glucose.2 
65 Epidemiological studies have suggested a link between exposure to some pesticides and development of 
66 diabetes mellitus,3-6 which is worrying in the light of the widespread use of pesticides – the annual global 
67 consumption of pesticides is estimated at 2.6 billion kilograms, 0.48 billion of which are insecticides.7 A recent 
68 systematic review and meta-analysis by Evangelou et al found a summary OR of 1.58 (95% confidence interval 
69 1.32-1.90) for diabetes mellitus when comparing top vs. bottom tertiles of any pesticide exposure.8
70 1.1 Rationale
71 Higher-than-optimal blood glucose and diabetes mellitus can be considered part of a pathophysiological 
72 spectrum rather than separate entities, and higher-than-optimal blood glucose levels below the diagnostic 
73 limits for diabetes are responsible for 2.2 million deaths annually.2 The recent systematic review by Evangelou 
74 et al on the association between pesticides and diabetes mellitus8 did not include studies on diabetes-
75 associated metabolic traits. We believe that a new systematic review can add more knowledge to the 
76 evidence on the possible association between neuroactive non-organochlorine insecticides and diabetes by 
77 also including studies on impaired fasting glucose, glucose intolerance, insulin insensitivity, decreased insulin 
78 production and hyperglycaemia below the diagnostic limits for diabetes mellitus.
79 The majority of the studies included by Evangelou et al8 investigated organochlorine insecticides such as 
80 dichloro-diphenyl-trichloroethane (DDT). Pesticides are a heterogeneous group of compounds with different 
81 target organisms and modes of action,9 so it is imprudent to extrapolate health effects of one pesticide or 
82 class of pesticides to other classes of pesticides. Evangelou et al8 did not include all relevant classes of 
83 pesticides in their search string (e.g. it did not include organophosphate and neonicotinoid insecticides that 
84 have a 38% combined share of the insecticide market in monetary value10), and they also did not include 
85 individual pesticide names, even though articles on specific compounds may not include terms such as 
86 “pesticide” or “insecticide”. Furthermore, the filter “humans” was used when searching databases for 
87 epidemiological studies, which would have excluded articles that were incorrectly indexed. Taken together, 
88 this means that important evidence might have been missed.
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89 1.2 Description of the risk factor
90 Pesticides are compounds used for killing unwanted organisms, and  based on their target organisms they 
91 can be broadly categorized as insecticides, nematicides, rodenticides, herbicides or fungicides.9 These broad 
92 classes can be further subdivided based on the specific mode of action of individual compounds.9 Because of 
93 the broad definition of the term “pesticide”, it encompasses a huge number of chemical substances: in May 
94 2018 the European Union pesticide database alone contained 1,367 different active substances.11 We judge 
95 it of importance to evaluate the specific active substances separately. Because the previous systematic 
96 review on pesticides and diabetes was able to assess the neuroactive organochlorine insecticides,8 we  chose 
97 to focus on the neuroactive non-organochlorine insecticides that comprise 85% of the global market for 
98 insecticides in monetary value.10 A list of the classes of insecticides to be included can be seen in the section 
99 “Types of exposures” below, while individual compounds are listed in online appendix A. 
100 1.3 Description of the outcome
101 Apart from the morbidity and mortality directly associated with diabetes mellitus, it is a major risk factor for 
102 e.g. myocardial infarction, kidney failure, peripheral vascular disease and lower limb amputations.2 The 
103 disease is a continuous spectrum of hyperglycaemia, insulin insensitivity, and decreased insulin production. 
104 This is reflected in the changes of diagnostic criteria made by the World Health Organization based on studies 
105 showing negative health effects of hyperglycaemia: The 1980 cut-off for fasting plasma glucose was 8.0 
106 mmol/litre,12 changed to 7.8 mmol/litre13 in 1985 and to the current value of 7.0 mmol/litre in 1998.14 Even 
107 with the current definition, higher-than-optimal blood glucose values below the diagnostic cut-off are 
108 associated with significant morbidity and mortality.2
109 Because of the continuous nature of the disease process, this systematic review will focus on diabetes 
110 mellitus as defined by the diagnostic criteria at the time of the individual studies, but also include studies on 
111 hyperglycaemia, insulin insensitivity and decreased insulin production.
112 1.4 How the risk factor may impact the outcome
113 While physical inactivity, overweight and genetic disposition are important risk factors for diabetes mellitus,2 
114 chemical exposures can also play a role in its aetiology. It is well known that some drugs interfere with glucose 
115 regulation, increasing the risk of diabetes mellitus among predisposed individuals.1 The glucose analogue 
116 streptozotocin is selectively toxic to the insulin-producing beta-cells of the pancreas15 and is used to create 
117 rodent models of diabetes mellitus. The rodenticide Vacor was also toxic to beta cells and lead to a phenotype 
118 similar to type 1 diabetes in humans who attempted suicide with the compound.16
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119 A complete review of mechanisms that may link diabetes mellitus with exposure to neuroactive non-
120 organochlorine insecticides is out of scope of this protocol, but there are indications of a causal link. 
121 Hyperglycaemia has been reported in connection with human acute high-dose intoxication with 
122 pyrethroids,17 organophosphates,18 carbamates19 and neonicotinoids20. While hyperglycaemia is a part of the 
123 acute stress response,21 and the hyperglycaemia seen in acute high-dose poisoning may be an unspecific 
124 marker of physiological stress, a plethora of possible mechanisms by which insecticide exposure might lead 
125 to diabetes mellitus and related metabolic disturbances has been suggested. Depending on the specific 
126 compound or class of compounds, mechanisms may include changes in lipid metabolism,22 inflammation,22 
127 oxidative stress,22 changes in the gut microbiome,3 interference with insulin release from the beta cells of 
128 the pancreas,22 or other endocrine-disruptive effects.23
129 2 Objectives
130 We aim through a systematic review and meta-analysis to assess whether exposure to specific classes of 
131 neuroactive non-organochlorine insecticides at levels too low to cause acute intoxication is associated with 
132 diabetes mellitus, or related metabolic traits such as prediabetes (impaired fasting glucose or glucose 
133 intolerance), hyperglycaemia, or insulin resistance.
134 3 Methods
135 The systematic review will be carried out according to the Navigation Guide guidelines for systematic reviews 
136 in environmental health24, and will be reported in accordance with the Preferred Reporting Items for 
137 Systematic Reviews and Meta-Analyses (PRISMA) guidelines.25 This protocol conforms to the PRISMA 
138 Protocols (PRISMA-P) guidelines, and its abstract conforms to the PRISMA for Abstracts (PRISMA-A) 
139 guidelines.26 In case any methodological changes from this protocol are made during the review, they will be 
140 listed under the heading “Differences between protocol and review” in the final article.
141 3.1 Eligibility criteria
142 3.1.1 Types of populations
143 Any human population.
144 3.1.2 Types of exposures
145 Occupational or environmental exposure to neuroactive non-organochlorine insecticides, defined as non-
146 organochlorine insecticidal compounds whose main toxico-dynamic target is the nervous system according 
147 to the classification system by the Insecticide Resistance Action Committee.27 We will not include DDT, its 
148 analogues or other organochlorine insecticides, since they have been reviewed recently8 and furthermore 
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149 most of these compounds are already severely restricted due to health risk concerns,28 and currently have a 
150 small market share.10 Nor will we include nicotine, even though it can be categorized as a neuroactive 
151 insecticide, because we consider it obsolete as a pesticide, and it is estimated to have no significant market 
152 share.10
153 Specifically, the included classes of insecticides are:
154  Carbamates
155  Organophosphates
156  Fiproles
157  Pyrethroids and pyrethrins
158  Neonicotinoids
159  Sulfoximines
160  Butenolides
161  Spinosyns
162  Avermectins and milbemycins
163  Pymetrozine
164  Flonicamid
165  Nereistoxin analogs
166  Amitraz
167  Oxadiazines
168  Semicarbazones
169  Diamides
170 The individual insecticides in these classes can be seen in appendix A.
171 We will include studies with quantitative measures of exposure, as well as more crude exposure measures 
172 (such as professions/industries/work sites), as long as the insecticide used is stated and falls within one of 
173 the above-mentioned categories.
174 3.1.3 Types of comparators
175 Humans exposed to no or lower levels of neuroactive non-organochlorine insecticides than the more highly 
176 exposed population.
177 3.1.4 Types of outcomes
178 While the main outcome of interest is diabetes mellitus, we will also include studies on the additional 
179 outcomes shown in Table 1 Types of included outcomesTable 1.
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180 Table 1 Types of included outcomes
Classification in ICD-10*, if applicable
Condition
Name Code
Diabetes mellitus Diabetes mellitus E10-E14
Hyperglycaemia/increased blood glucose levels Hyperglycaemia, unspecified R73.9
Impaired fasting glucose - -
Glucose intolerance Abnormal glucose tolerance test R73.0
Insulin insensitivity - -
Decreased insulin production - -
181 * ICD-10 = International Classification of Diseases, 10th Revision.29
182 When the outcome in a study is diabetes mellitus, it must be defined by register data, fasting plasma glucose, 
183 oral glucose tolerance test, glycated haemoglobin A (HbA1c), or a combination of at least one of these 
184 measures, optionally in combination with patient self-report. We will not include studies where diabetes 
185 mellitus is defined only by patient self-report or by measurement of random plasma glucose or glycosuria.
186 3.1.5 Types of studies
187 3.1.5.1 Inclusion criteria
188 Any type of epidemiological (cross-sectional, case-control, cohort, ecological etc.) and human exposure 
189 studies providing an exposure contrast to the neuroactive non-organochlorine insecticides listed in appendix 
190 A and a measure of association to the outcomes of interest. Studies without a measure of association will be 
191 included if they provide enough information to calculate such a measure.
192 3.1.5.2 Exclusion criteria
193  Case reports, case series, animal studies, ex vivo studies (including studies on human cells and 
194 tissues) and in silico studies.
195  Studies only considering exposure to “insecticides” or “pesticides” as broad categories, or exposure 
196 to a mixture of pesticides that includes compounds that cannot be classified as neuro-active non-
197 organochlorine insecticides.
198  Studies without estimates of association (e.g. only reporting prevalence or incidence of diabetes in 
199 an insecticide-exposed group, but without a control group).
200  Studies on insecticide poisoning requiring acute medical treatment.
201 3.1.5.3 Years considered
202 Any year of publication. All searches will be re-run within 12 months of publication of the systematic review. 
203 New hits will be screened in the same manner as hits in the original search (see below). When deciding on 
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204 whether to include new eligible studies in the systematic review, their potential influence on the conclusions 
205 of the systematic review will be weighed against the resulting delay in publication. If we choose not to include 
206 such new studies, we will provide a comprehensive list of the studies in an appendix.
207 3.1.5.4 Publication language
208 We will not exclude any articles based on language, but we will only actively search for articles using English 
209 terms (except for the LILACS database, where Spanish, French and Portuguese terms will also be used). 
210 Articles in languages other than the ones spoken by the reviewers (Danish, English, German, Norwegian and 
211 Spanish) will be translated into English using Google Translate (https://translate.google.com/). 
212 3.1.5.5 Publication status
213 Peer-reviewed publications.
214 3.1.6 Types of effect measures
215 For binary outcomes, we will prioritize relative effects measures such as risk ratio, odds ratio and hazard ratio 
216 depending on the study design. Absolute effect measures will be considered if no relative effect measures 
217 are available. For continuous outcomes such a fasting plasma glucose, we will include both relative and 
218 absolute effect measures.
219 If results from both unadjusted and adjusted analyses are presented in a study, we will include results from 
220 the most adjusted one, unless we suspect over-adjustment (i.e., adjustment for a factor that is on the causal 
221 path from exposure to outcome), in which case we may choose a less adjusted model.
222 Because of the known and strong correlations between e.g. family history, age and diabetes mellitus, we will 
223 not be able to convert adjusted odds ratios for diabetes mellitus into relative risks, since the conversion 
224 requires an a common “assumed control risk” for all the non-exposed persons.30 We will only combine 
225 adjusted odds ratios and adjusted relative risks in meta-analysis if the prevalence of diabetes mellitus in the 
226 studies reporting odds ratios is ≤ 10%, since the odds ratio will then be numerically very similar to the relative 
227 risk.31 
228 3.2 Information sources and search
229 Searches will be performed in the following scientific databases:
230  NCBI PubMed
231  Embase
232  Scopus
233  Web of Science
234  LILACS (http://lilacs.bvsalud.org) 
235 The search terms for each of these 5 databases are included in online appendices B-F.
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236 A hand search for potentially eligible articles will be performed in the reference list of included articles, 
237 among the articles that cite any of the included articles, and in the reference lists of existing reviews on the 
238 subject. Experts on negative health effects of pesticides will be presented with the list of included studies 
239 and will be asked to identify any further eligible studies.
240 The removal of in vitro, in silico and animal studies (see eligibility criteria above) will be done manually rather 
241 than by the use of search filters because studies might have been erroneously indexed in the article 
242 databases.
243 3.3 Study selection
244 Two independent reviewers (MRHH and JS) will screen search hits for eligibility first at the title, then at the 
245 abstract and finally at the full text level. Conflicts will be solved by consulting a third review author. In the 
246 systematic review, a flow-chart of article in- and exclusion will be provided in accordance with the PRISMA25 
247 guidelines.
248 3.4 Data extraction and data items
249 Records and data will be managed using the DistillerSR32 web application for systematic reviews. Two 
250 independent investigators (MRHH and JS) will design and pilot data extraction forms until agreement is 
251 achieved, with mediation by a third investigator if agreement cannot be achieved. Data entry will also be 
252 extracted by two separate investigators (MRHH and JS), with mediation by a third investigator in case of 
253 disagreements.
254 We will prepare three separate data extraction forms – one for extracting study characteristics, one for 
255 assessing risk of bias (see included parameters in the section “Risk of bias assessment”), and one for 
256 extracting effect estimates. The forms will be filled out in the order listed (i.e. risk of bias assessment will be 
257 done before extraction of effect estimates).
258 As a minimum, the study characteristics form will include the following information on each primary study:
259  First author name
260  Year of publication
261  Region
262  Study design (cross-sectional, case-control, cohort, etc.). Will be assessed by the systematic review 
263 authors instead of using labels used by investigators in primary study.
264  Participants
265 o Exposed population
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266 o Comparators
267 o Percent participation 
268  Exposure
269 o Type of exposure (environmental or occupational)
270 o Assessment method (biomarker, environmental measurements, register or questionnaire)
271 o Specific insecticides assessed
272  Outcome
273 o Type of outcome (diabetes mellitus, insulin insensitivity, fasting blood glucose as continuous 
274 measure, etc.). If the outcome is diabetes mellitus, we will record whether it was type 1, type 
275 2 or unspecified (assessed by systematic review authors; we will not rely on labels used by 
276 investigators in primary study).
277 o Definition of outcome by the study authors.
278 The form for extracting effect estimates will have separate fields for each identified exposure-outcome pair. 
279 Effect estimates will be extracted with their 95% confidence intervals. If no confidence interval is available, 
280 but an exact p-value is, we will extract the p-value and calculate a 95% confidence interval.
281 Any missing data deemed necessary for the systematic review will be requested from the corresponding 
282 author of the primary study in question.
283 3.5 Risk of bias assessment
284 Risk of bias will be considered both at the outcome and the individual study level. The risk of bias at the 
285 outcome level will be assessed as part of the assessment of the quality of evidence (see below). All 
286 assessment of risk of bias will be done by two separate investigators with mediation by a third investigator 
287 in case of disagreements.
288 Risk of bias at the individual study level will be assessed according to the Navigation Guide systematic review 
289 methodology as illustrated by a previous systematic review on the reproductive toxicity of the biocide 
290 triclosan.33 For each domain in the risk of bias assessment (e.g., “exposure assessment” or “confounding”), 
291 the support for judgement (in the form of verbatim quotes from the original articles and/or comments from 
292 the systematic review authors) will be provided as suggested by the Cochrane Handbook.34 In the domain 
293 “Conflict of interest”, we will include author financial conflicts of interest and study funding from the 
294 agrochemical, agricultural or food industries. Both disclosed and undisclosed conflicts will be included as 
295 described in a systematic review by Mandrioli et al.35 
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296 3.6 Assessing quality of evidence
297 The quality of evidence at the level of each exposure-outcome pair will be graded according to the Grading 
298 of Recommendations Assessment, Development, and Evaluation (GRADE) guidelines36, adapted to the setting 
299 of occupational medicine.37 We will include an assessment of the risk of meta-biases due to publication bias 
300 and selective reporting. Risk of publication bias will be assessed qualitatively if we identify 9 studies or less 
301 for an exposure-outcome pair, while we will use funnel plots if we identify at least 10 studies. To assess the 
302 risk of bias due to selective reporting, we will attempt to locate published protocols of included studies.
303 3.7 Summary measures and synthesis of results
304 For each exposure-outcome pair where we include two or more studies, we will qualitatively assess whether 
305 the studies are sufficiently similar in exposed population, comparator and type of effect estimate to allow 
306 quantitative synthesis in a meaningful manner. E.g., studies on environmentally and occupationally exposed 
307 persons will not be combined quantitatively, unless biomarkers show that exposure levels are comparable. 
308 This assessment will be done by two separate investigators, with mediation by a third investigator in case of 
309 disagreements. If quantitative synthesis is deemed inappropriate, we will synthesize the results qualitatively 
310 based on their consistency. If we deem that at least two studies are sufficiently similar for quantitative 
311 analysis, we will test for study heterogeneity using the I2 statistic.31 If no significant heterogeneity is 
312 identified, results will be synthesized in a meta-analysis using the inverse variance method with a random 
313 effects model.31 Adjusted and unadjusted effect estimates will not be combined quantitatively. The summary 
314 measures will depend on the effect measures reported in the individual studies. E.g., if articles report odds 
315 ratios, we will calculate meta-odds ratios, and if articles report regression coefficients from linear regression 
316 models on blood glucose values, we will calculate meta-coefficients.
317 3.8 Additional analyses
318 To assess the impact (direction and size) of the risk of bias in individual studies, we will repeat any 
319 quantitative synthesis of results for each exposure-outcome pair, stratified by overall risk of bias (low risk or 
320 probably low risk vs. probably high risk, high risk or unclear risk) provided that each stratum contains at least 
321 two studies. If the strata contain less than two studies each, we will qualitatively assess the impact of the risk 
322 of bias.
323 Since in silico, in vitro and animal studies will not be included in the systematic review, we will refrain from 
324 speculating on the possible mechanistic links between exposure to neuroactive non-organochlorine 
325 insecticides and disruption of glucose homeostasis. Also, since we will not review the benefits of using these 
326 compounds (e.g., in agriculture and public health programs targeted against malaria) in this systematic 
327 review, we will give no recommendations regarding their use.
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328 3.9 Data sharing
329 The DistillerSR database used in the systematic review will be exported and included in the final publication 
330 as an online supplement to ensure complete transparency.
331 4 Financial support
332 The development of this protocol was not supported by any specific grant from funding agencies in the public, 
333 commercial, or not-for-profit sectors. We will not apply for any funding for the systematic review, apart from 
334 as needed to pay open access publication fees.
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336 The authors declare that they have no conflicts of interest in relation to the subject of the systematic review.
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338 MRHH and VS contrived the systematic review. MRHH and VS gathered the review team. MRHH and VS lead 
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340 systematic review. MRHH wrote the first draft of this protocol and EJ, AS, HAK, JS and VS made substantial 
341 contributions to the designs of the systematic review and to revisions of the manuscript. MRHH is the 
342 guarantor of the systematic review.
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430 Appendix A: List of insecticides to be considered in the 
431 systematic review
432  Carbamates: Alanycarb, aldicarb, aminocarb, bendiocarb, benfuracarb, butocarboxim, 
433 butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, fenothiocarb, 
434 fenoxycarb, formetanate, furathiocarb, isolan, isoprocarb, methiocarb, methomyl, metolcarb, 
435 oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate,trimethacarb, XMC, xylylcarb
436  Organophosphates: Acephate, amiton, azamethiphos, azinphos-ethyl, azinphosmethyl, cadusafos, 
437 chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, coumaphos, 
438 crufomate, cyanophos, cyanofenphos, cythioate, demeton-S-methyl, diazinon, dichlorvos/DDVP, 
439 dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion, ethoprophos, etrimfos, 
440 famphur, fenamiphos, fenitrothion, fenthion, fonofos, formothion, fosthiazate, fensulfothion, 
441 heptenophos, imicyafos, isofenphos, isopropyl O-(methoxyaminothio-phosphoryl) salicylate, 
442 isoxathion, leptophos, malaoxon, malathion, mecarbam, methacrifos, methamidophos, 
443 methidathion, mevinphos, mipafox, monocrotophos, naled, omethoate, oxydemeton-methyl, 
444 parathion, parathion-methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, 
445 pirimiphos-methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, 
446 sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, tributyl 
447 phosphorotrithioite, trichlorfon, vamidothion
448  Fiproles: Ethiprole, fipronil
449  Pyrethroids and pyrethrins: Acrinathrin, allethrin, bifenthrin, bioallethrin, bioresmethrin, 
450 cycloprothrin, cyfluthrin, cismethrin, cyhalothrin, cypermethrin, cyphenothrin, deltamethrin, 
451 empenthrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin, tau-
452 fluvalinate, halfenprox, imiprothrin, kadethrin, permethrin, phenothrin, prallethrin, pyrethrum, 
453 resmethrin, silafluofen, tefluthrin, tetramethrin, tralomethrin, transfluthrin
454  Neonicotinoids: Acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, nithiazine, 
455 thiacloprid, thiamethoxam
456  Sulfoximines: Sulfoxaflor
457  Butenolides: Flupyradifurone
458  Mesoionics: Triflumezopyrim
459  Spinosyns: Spinetoram, spinosad
460  Avermectins and milbemycins: Abamectin, emamectin benzoate, lepimectin, milbemectin
461  Pyridine azomethine derivatives: Pymetrozine, pyrifluquinazon
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462  Flonicamid
463  Nereistoxin analogs: Bensultap, cartap hydrochloride, thiocyclam, thiosultap-sodium
464  Amitraz
465  Oxadiazines: Indoxacarb
466  Semicarbazones: Metaflumizone
467  Diamides: Chlorantraniliprole, cyantraniliprole, flubendiamide
468 List of classes of insecticides compiled from the IRAC Mode of Action Classification Scheme.27 Individual 
469 pesticide names extracted from the same publication, supplemented with the WHO Recommended 
470 Classification of Pesticides by Hazard and Guidelines to Classification 200938 and (for the classes of 
471 carbamates, neonicotinoids, pyrethroids and organophosphates) Embase Emtree.
472 If additional compounds belonging to the above-mentioned classes of insecticides are identified during the 
473 review process, we may include them as well.
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